This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A growing consumer demand for sustainable and health-focused travel options is pushing the hospitality industry to innovate and prioritize wellness to meet these evolving expectations. Another critical challenge is navigating the balance between sanitation and sustainability.
Pharmacokinetic (PK) data showed a half-life of approximately 75 days across doses tested and pharmacodynamic (PD) data showed, deep and sustained inhibition of key atopic dermatitis (AD) biomarkers pSTAT6 and TARC for ~3 months (longest follow-up available, with inhibition still ongoing at time of the data cut).
So far we’ve hosted a sustainability conference in March, as well as a collab conference with Michelle @labmuffinbeautyscience on sunscreen in May. There, he led the Product Safety group for 25 years. His product safetyportfolio included: Jergens and Curel lotions, Biore face care, Ban antiperspirant, and John Frieda hair care.
Apogee Therapeutics recently hosted its first R&D Day, which featured updates across its entire portfolio. Single doses of APG777 led to prolonged signal transducer and activator of transcription 6 (pSTAT6) inhibition for up to 12 months and deeper, more sustained thymus and activation-regulated chemokine (TARC) reduction.
So far we’ve hosted a sustainability conference in March. Next up, we’ll be tackling the topic of safety, coming your way in late September. His current focus is on Sun care, Color cosmetics and Sustainable innovation. This was our attempt to democratize accurate information for the cosmetics industry.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content